Results 101 to 110 of about 29,663 (265)

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand. [PDF]

Clin Exp Vaccine Res, 2023
Sirithammaphan U, Chaisang U, Pongrattanamarn K.   +2 more
europepmc   +1 more source

Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age [PDF]

, 2018
H. Haas, Patrick O. Richard, Cécile Eymin, Anne Fiquet, Barbara J. Kuter, B. Soubeyrand   +5 more
openalex   +1 more source

Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children

The Turkish Journal of Pediatrics, 2000
A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj  

Seroprotection to vaccine‐preventable diseases among workers at a Victorian tertiary hospital

Australian and New Zealand Journal of Public Health, 2016
Objective: To determine seroprotection for the vaccine‐preventable diseases (VPDs) measles, mumps, rubella, varicella and hepatitis B among new employees seen at a Victorian tertiary hospital staff clinic.
Eden C. Andrew, Katherine B. Gibney, Justin Denholm, Karin Leder   +3 more
doaj   +1 more source

Determinação da susceptibilidade ao sarampo, rubéola, papeira e varicela nos estudantes das áreas ligadas à saúde.

Acta Médica Portuguesa, 1999
We present an epidemiological and serological study in 286 health care students. We found susceptibility for measles in 11.7% individuals (95% confidence interval (95% CI): 8.0-15%), for rubella: 6.7% (95% CI: 3.8-9.6%) for mumps: 12.7% (95% CI: 8.0-16.6%
J Oliveira, N Dias, T M Ferreira, S da Cunha, D Costa, R Côrte-Real, A Meliço-Silvestre   +6 more
doaj   +1 more source

A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults [PDF]

, 2019
Patricia Kaaijk, Alienke J. Wijmenga‐Monsuur, Marlies A. van Houten, Irene Veldhuijzen, Hinke I ten Hulscher, Jeroen Kerkhof, Fiona van der Klis, Rob van Binnendijk   +7 more
openalex   +1 more source

Measles, Mumps, and Rubella Antibody: Patterns of Persistence and Rate of Decline Following the Second Dose of the MMR Vaccine [PDF]

, 2017
Emma E. Seagle, Robert A. Bednarczyk, Tenisha Hill, Amy Parker Fiebelkorn, Carole J. Hickman, Joseph P. Icenogle, Edward A. Belongia, Huong Q. McLean   +7 more
openalex   +1 more source

Genetics and measles, mumps and rubella vaccine response in childhood and adolescence—A systematic review [PDF]

, 2023
Marie Mykløy Haslund, Jesper Kiehn Sørensen, Lone Graff Stensballe   +2 more
openalex   +1 more source

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy

Vaccines
Background: Despite the efforts of the World Health Organization, some childhood viral diseases, for which there is already an effective vaccine, have not yet been eradicated. Among these, we find varicella, mumps, measles, and rubella, which although in
Brunella Perfetto, Giovanna Paduano, Elena Grimaldi, Vincenza Sansone, Giovanna Donnarumma, Gabriella Di Giuseppe   +5 more
doaj   +1 more source

Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]

Oman Med J, 2022
Al-Mendalawi MD.
europepmc   +1 more source